Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
7 participants
INTERVENTIONAL
2023-02-22
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Is imagery rehearsal therapy (IRT) effective for narcolepsy-related nightmares?
* Does adding targeted dream control (TDC) to IRT make it more effective?
Participants will be randomized to one of two treatment groups and will be asked to:
* Complete a daily log of sleep symptoms for up to 13 weeks.
* Attend 7 sessions of treatment.
* Complete questionnaires before and after treatment.
* Go to the research lab in Evanston, IL to complete a sleep study during a daytime nap (Chicago area residents only).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Decreasing Nightmares in Adults With Narcolepsy
NCT06383806
Psychosocial Adjunctive Treatment for Hypersomnia (PATH)
NCT03904238
Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments
NCT05371483
Pilot Study Comparing the Effectiveness of Two Different Methods of Acoustic Stimulation
NCT03600194
Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions
NCT06457945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Imagery rehearsal therapy (IRT)
Participants randomized to this group will receive 7 sessions of IRT.
Imagery rehearsal therapy
Therapy to reduce nightmares, delivered via videoconference sessions
Imagery rehearsal therapy and targeted dream control (IRT+TDC)
Participants randomized to this group will receive 7 sessions of IRT+TDC.
Imagery rehearsal therapy
Therapy to reduce nightmares, delivered via videoconference sessions
Targeted dream control
Therapy to reduce nightmares, delivered in videoconference sessions and lab session. Lab session will involve a sleep study during a daytime nap.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Imagery rehearsal therapy
Therapy to reduce nightmares, delivered via videoconference sessions
Targeted dream control
Therapy to reduce nightmares, delivered in videoconference sessions and lab session. Lab session will involve a sleep study during a daytime nap.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 or older
* Speak English
* Live in the United States
* Receiving standard medical care for narcolepsy
* Sleep and psychiatric medications stable for at least 3 months
* Nightmare frequency of ≥3 times per week
* Nightmare Disorder Index score indicates probable nightmare disorder
* Able to attend a study appointment in Evanston, IL
* Able and willing to not take wake-promoting medications on day of lab visit
Exclusion Criteria
* Currently engaged in sleep- or trauma-focused psychotherapy
* Previous behavioral treatment for nightmares
* Medical, psychiatric, or cognitive condition which would interfere with ability to engage in the treatment
* Untreated sleep apnea (AHI ≥ 5)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Mundt, PhD
Role: PRINCIPAL_INVESTIGATOR
Northwestern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern University
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00218129
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.